Chain Drug Review
  Chain Drug Review is free to qualified professionals. Summary Description
  To apply for a FREE subscription to Chain Drug Review, please answer ALL of the questions on the form below.
  The magazine publisher determines qualification and reserves the right to limit the number of free subscriptions.
  Geographic Eligibility: USA, Canada


 
1. Do you wish to receive a FREE subscription to Chain Drug Review?
Yes     No


First Name:
Last Name:
Job Title:
(Ex: Director, Vice President, Project Manager, etc.)
Company Name:
(Please provide your Company Name in full: abbreviations could disqualify you)
Department/Mail Stop/Suite:
Address:
City:
State/Province:
Zip/Postal Code:
Country:
(Note: If your country is not listed above, subscriptions are not currently available at your location.)
Phone:
Fax:
Email Address:
(Note: Valid email address is required or you could be disqualified.)
By providing your email address, you are granting Chain Drug Review permission to contact you regarding your subscription. Please note, your email address will not be shared with any third party. If you do not wish to receive other email promotions from Chain Drug Review/Racher Press Inc., check here.
  What is the approximate number of employees in your company? (select only one)
 
Yes, please auto-fill my contact information for other publication qualification forms.


2. In lieu of a signature, we require a unique identifier used only for subscription verification purposes. What state were you born in?


3. My title is: (select only one)
Pres/CEO/Owner/Chairman Pharmacy Mgr.
VP/Director/GM/Other (please specify) Pharmacist
Pharmacy Technician
Buyer/Category Mgr./Merchandiser Other (please specify)
District/Regional Mgr.


4. My primary business activity is: (select only one)
Drug (Chain) On-line retailer
Drug (Franchise) Association/Gov't Agency
Supermarket/Discount Other (please specify)
Wholesaler


5. My Business Location is best described as: (select only one)
Headquarters Location of a chain Independent/Single Unit Establishment
District/Regional Location of a chain Other (please specify)
Store Location of a chain


6. Number of Stores my business operates: (select only one)
1 Store 11-49 stores
2-3 stores 50-99 stores
4-10 stores 100 + stores


7. Do you recommend, approve or purchase any of the products listed below? (select all that apply)
H&BA/Cosmetics Magazines/Books
Rx Drugs/Generics Snacks/Beverages
OTC Drugs/Vitamins Automotive
Photo/Batteries Toys
Jewelry Audio Video
Tobacco Private Label
Greeting Cards/Stationary Other (please specify)
None of the above


  Would you like to receive EMAIL notices of other print or online publications, and other relevant offers from TradePub.com?
Yes     No
  Sign up for special offer alerts from select partners featuring the latest products and services you are interested in.
Yes     No

 
Related FREE Offers from TradePub.com: Check those you wish to receive.

Sign up for the PharmaWeek Newsletter Today and receive breaking R&D news and business insights for biopharmaceutical company managers- a top-line look at the pharmaceutical world and surrounding arenas, and exclusive analysis on major trends, key strategies, general business insights, and career resources. Note: Offer Valid in the United States & Canada Only.
  What category best describes your JOB FUNCTION? (select only one)
  What is your primary BUSINESS ACTIVITY at this business location? (select only one)
  You may receive emails from CHI regarding your subscription. If you do not want to receive this, please check no.
Yes     No
  You may also receive email from CHI partners whose products match your interests. If you do not want this, please check no.
Yes     No

FierceVaccines is an easy to read weekly email service that brings must read vaccine news to lab researchers in the vaccine industry, keeping you up to speed on the latest news and trends, with a special focus on the innovations revolutionizing the development and production of vaccines. Our goal is to save you time and help you stay ahead of the competition. Learn why thousands of top lab research professionals rely on FierceVaccines for their weekly vaccine news. Note: Offer Valid in the United States, Canada, Mexico, United Kingdom Only.
  What is your job function? (select only one)
Executive Managment Group Project Leader
Research/Development Graduate Student/Researcher
Principal Investigator Sales & Marketing
Lab Director Business Development
Research Scientist Finance, Investment
Lab Technician Student
Postdoc Scientist Other
  Please select your company type. (select only one)
Emerging & Mid-Tier Biotech/Pharma Diagnostic & Device
Large Pharma Academic
Clinical/Contract Research Organization (CRO) Gov't, Non-Profit
Service/Supply/Manufacturing Other

Request your free On-Demand Webcast - Going Green: What's Good for the Environment is Good for Business. View this informative webcast featuring Gartner "Green IT / high performance workplace" analyst Mark Gilbert and Xerox VP of Environment, Health and Safety, Patricia Calkins. Discover how you can:
  • Adopt policies that reduce waste, energy use, and greenhouse gasses while increasing efficiencies / ROI.
  • Create an "early win" using Enterprise Content Management (ECM) solutions that will save your organization paper, energy, time, money, and waste.
  • Employ some of the steps that Xerox and its customers have taken to dramatically reduce their carbon footprint and cut costs.
Note: Offer Valid in the United States and Canada Only.
  What is the number of employees in your entire organization? (select only one)
1-99 1,000-4,999
100-999 5,000+
  Do you currently have a budget defined for your project?
Yes     No

If Yes, are you the budget owner?

Yes     No
  How many months have you been researching potential solutions? (select only one)
0-3 months 6-9 months
3-6 months 9-12 months
  What is your timeframe for making a purchasing decision? (select only one)
90 days or less 181 days to 270 days
91 to 180 days 271 days to 360 days

Request your FREE White Paper: How To Get To The Numbers That Matter. The paper addresses a wide range of topics that impact a retailer's financial success. Many of these are common to retailers of all sizes, but some are specific to mid to small tier businesses and many cautionary notes are given. The objective of this white paper is to review various aspects of retail financial management and to draw important lessons for small and mid-size retailers. This white paper was written by Martec International, Inc., Compliments of Microsoft Corporation. Note: Offer Valid in the United States Only.
  Company Employee Size: (select only one)
1-4 500-999
5-10 1,000-1,499
11-24 1,500-4,999
25-49 5,000-24,999
50-99 25,000-49,000
100-249 50,000 or more
250-499
  Job Role/Title: (select only one)
EXECUTIVE MANAGEMENT TECHNOLOGY PROFESSIONAL continue
CEO - Chief Executive Officer Systems Engineer
CFO - Chief Financial Officer Web Developer/Designer
CIO - Chief Information Officer Web Master
Director BUSINESS PROFESSIONAL
General Manager Analyst
Owner Contract Specialist
President Controller
Vice President Corporate Attorney
TECHNOLOGY PROFESSIONAL Manager
Database Administrator Project Director/Manager
Developer Sales Representative
Helpdesk Technician Technical/Business Consultant
Infrastructure Architect Trainer
IT Implementor OTHER
LAN Administrator Other
Strategy Architect
  Microsoft may send me pertinent security, product, and event information via: (select all that apply)
Work Address
Email Address
Business Phone Number
Microsoft Partners may contact me with information about their products, services, and events.


     

* Note that a valid email address is required to fulfill your request. Please verify that the email and mailing address you provided are accurate before hitting the submit button.
* The publisher reserves the right to limit the number of free subscriptions and/or reject requests based on information provided.


Problems with the form? Webmaster@TradePub.com
Copyright © 2008 NetLine Corporation, All Rights Reserved.
Copyright © 2008 Chain Drug Review, All Rights Reserved.